BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, February 21, 2026
Home » Authors » Larry Haimovitch

Articles by Larry Haimovitch

New Horizons Glaucoma Forum: MIGS seen as the 'new sexy' in the glaucoma device world

Feb. 7, 2013
By Larry Haimovitch

J.P. Morgan Healthcare Conference: Private ophthalmic companies make pitches to audience

Jan. 15, 2013
By Larry Haimovitch
SAN FRANCISCO — Private companies continued to be of great interest at this conference and one of the most keenly anticipated presentations was from Bausch + Lomb (B + L; Rochester, New York). B + L, which was founded in 1853, is one of the oldest continuous operating companies in the U.S. and has one of the best-known healthcare brands in the world.
Read More

Lasik procedures head up discussions at AAO meeting

Nov. 19, 2012
By Larry Haimovitch
CHICAGO — The annual meeting of the American Academy of Ophthalmology (AAO; San Francisco), the largest ophthalmic meeting of the year, took place here in the past few days, with an estimated 26,000 persons from around the world in attendance. The meeting was conducted in conjunction with the Asia-Pacific Academy of Ophthalmology.
Read More

TCT 2012: PFO clinical trial results: more questions than answers

Oct. 30, 2012
By Larry Haimovitch

Aesthetics market earns its close-up at Canaccord conference

Aug. 22, 2012
By Larry Haimovitch

Wilson Sonsini conference: Meeting focuses on capital investment for med-tech

June 27, 2012
By Larry Haimovitch

HRS 2012: New AF mapping technology data may finally silence the skeptics

May 15, 2012
By Larry Haimovitch

Conference's 'vision' allows industry leaders second sight

April 27, 2012
By Larry Haimovitch

Society of Interventional Radiology: Meeting spotlights future patient care improvements

April 3, 2012
By Larry Haimovitch
SAN FRANCISCO The 37th annual meeting of the Society of Interventional Radiology (Fairfax, Virginia) took place here last week and showcased several technologies and procedures which show promise to improve patient care and become important contributors in the future.
Read More

Glaucoma New Horizons Forum: Glaucoma forum seeks to prevent the notorious 'silent thief of sight'

Feb. 8, 2012
By Larry Haimovitch
Previous 1 2 3 4 5 6 7 8 9 … 18 19 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing